Impact of Lynch syndrome, BRAFV600E, and RAS mutations on outcomes in MSI/dMMR metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI): Analysis of combined international cohorts
Colle, R., Lonardi, S., Cachanado, M., Overman, M. J., Elez, E., Fakih, M., . . . Andre, T. (2023). Impact … Read More
